A phase II study of irofulven in women with recurrent and heavily pretreated ovarian cancer. (Record no. 15886757)

MARC details
000 -LEADER
fixed length control field 01637 a2200469 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250515004349.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 200604s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0090-8258
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1016/j.ygyno.2005.09.036
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Seiden, Michael V
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20060427
245 00 - TITLE STATEMENT
Title A phase II study of irofulven in women with recurrent and heavily pretreated ovarian cancer.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Gynecologic oncology
Date of publication, distribution, etc. Apr 2006
300 ## - PHYSICAL DESCRIPTION
Extent 55-61 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged, 80 and over
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Agents, Alkylating
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cohort Studies
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Resistance, Neoplasm
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Infusions, Intravenous
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Neoplasm Recurrence, Local
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Organoplatinum Compounds
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Ovarian Neoplasms
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Sesquiterpenes
General subdivision adverse effects
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Gordon, Alan N
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Bodurka, Diane C
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Matulonis, Ursula A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Penson, Richard T
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Reed, Eddie
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Alberts, Dave S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Weems, Garry
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Cullen, Michael
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name McGuire, William P
773 0# - HOST ITEM ENTRY
Title Gynecologic oncology
Related parts vol. 101
-- no. 1
-- p. 55-61
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1016/j.ygyno.2005.09.036">https://doi.org/10.1016/j.ygyno.2005.09.036</a>
Public note Available from publisher's website

No items available.